The ADAPTABLE trial and aspirin dosing in secondary prevention for patients with coronary artery disease

A Johnston, WS Jones, AF Hernandez - Current cardiology reports, 2016 - Springer
… with either high or low-dose aspirin plus clopidogrel for … increased risk of bleeding with
aspirin treatment is widely recognized but the dose-risk relationship, especially in doses between

Antithrombotic strategies for preventing long-term major adverse cardiovascular events in patients with non-valvular atrial fibrillation who undergo percutaneous …

M Pareek, DL Bhatt, JM Ten Berg… - Expert Opinion on …, 2017 - Taylor & Francis
increased risk of recurrent ischemia or death. Completed trials make a compelling case for
double therapy with clopidogrel, not aspiringreater risk of bleeding compared with clopidogrel

The use of aspirin for primary and secondary prevention in venous thromboembolism and other cardiovascular disorders

AT Cohen, S Imfeld, J Markham, S Granziera - Thrombosis research, 2015 - Elsevier
… medical patients at increased risk of thrombosis who are not currently experiencing bleeding
and are not at high risk of … Antiplatelet therapy with aspirin plus clopidogrel or aspirin alone (…

Clopidogrel non-responsiveness and risk of cardiovascular morbidity

F Sofi, R Marcucci, AM Gori, B Giusti… - Thrombosis and …, 2010 - thieme-connect.com
… outcomes in patients with coronary artery disease (CAD) … date, the dual therapy with aspirin
and clopidogrel, that has been … with an increased risk of adverse clinical cardiac events (OR …

Aspirin for the primary prevention of cardiovascular events: recommendation and rationale

US Preventive Services Task Force* - Annals of Internal Medicine, 2002 - acpjournals.org
… evidence that aspirin decreases the incidence of coronary heart disease in adults who
are at increased risk for heart disease. It also found good evidence that aspirin increases the …

Combined clopidogrel and proton pump inhibitor therapy is associated with higher cardiovascular event rates after percutaneous coronary intervention: a report from …

T Burkard, CA Kaiser… - Journal of internal …, 2012 - Wiley Online Library
… (DAPT) consisting of aspirin (ASA) and clopidogrel is a cornerstone in … to prevent early and
late in-stent thromboses [5, 6]. … between PPI and clopidogrel to patients who are at high risk of …

[HTML][HTML] Pros and cons of aspirin for the primary prevention of cardiovascular events: a secondary study of trial sequential analysis

B Zhao, Q Wu, L Wang, C Liao, Y Dong, J Xu… - Frontiers in …, 2021 - frontiersin.org
… Currently, many patients are at high risk because their health is influenced by occlusive …
In this study, CV event risk was reduced by 11% in the low 10-y MACE% risk group. …

Aspirin and clopidogrel: a sweeping combination in cardiology

AS Manolis, S Tzeis, G Andrikopoulos… - … -Cardiovascular & …, 2005 - ingentaconnect.com
… for the treatment of symptomatic coronary artery disease. … of aspirin to prevent the recurrence
of a vascular event in 10-20… of increased risk of recurrent cardiovascular events during a 6-…

Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction

S Matetzky, B Shenkman, V Guetta, M Shechter… - Circulation, 2004 - Am Heart Assoc
… PCI who were already receiving aspirin was followed by a … patients with STEMI were resistant
to clopidogrel and subsequently were at increased risk of recurrent cardiovascular events

[HTML][HTML] Clinical importance of aspirin and clopidogrel resistance

G Feher, A Feher, G Pusch, K Koltai… - … journal of cardiology, 2010 - ncbi.nlm.nih.gov
… to aspirin because they exhibited significantly higher risks of … in preventing vascular events
as higher aspirin doses (500 to … of adverse cardiovascular events among patients undergoing …